New Delhi: The Indian government is holding talks with Johnson and Johnson for its single dose COVID-19 vaccine.
“We are in talks with Johnson & Johnson regarding their single-dose vaccine. Their vaccine is being produced outside,” Niti Ayog (health) member Dr VK Paul said during a press briefing on Friday.
Dr Paul also informed that the vaccine developed by the US pharmaceutical giant will be produced at Hyderabad-based Indian company Bio E.
“As per the plan, this vaccine will also be produced in Hyderabad’s Biological E,” Dr Paul said.
Johnson & Johnson recently said its vaccine is far more effective in neutralising Delta variants than against Beta variants.
Besides Covishield and Covaxin, India has approved two other vaccines so far — Moderna and Sputnik V.
Comments are closed.